Human cell transplants triggered immune responses in mouse retinas
An animal experiment detected responses against transplanted human bone marrow-derived cells 21 days after injection into the eyes of healthy mice.
Limit: Therapeutic benefits in neurodegenerative disease were not measured
Edited by Boris Djordjevic · AgingResearch.News
An experiment in healthy mice examined immune responses to human bone marrow-derived mesenchymal stromal cells, a type of supporting cell, transplanted into their eyes. After 21 days, researchers isolated immune cells from the retina, the light-sensing tissue at the back of the eye. They analyzed gene activity in individual cells, then investigated the findings using additional cellular tests and blood antibody analyses.
The transplants induced changes in gene activity consistent with immune activation and recruitment of white blood cells. The additional tests supported responses against the human cells involving both innate immunity, the body's general defenses, and adaptive immunity, its targeted defenses. The authors concluded that these cross-species transplants could overcome local mechanisms that normally limit immune responses.
Why it matters
Cell-based regenerative therapies are being explored for neurodegenerative disorders. The findings highlight immune barriers that researchers need to consider when developing cross-species approaches.
Caveats
The experiment examined cross-species transplantation in healthy mouse retinas, not therapeutic benefits in neurodegenerative disease or responses in people. The single-cell gene activity analysis was exploratory.
- Mesenchymal stromal cell transplantation
- Immune response
- CD45-positive and/or CD11b-positive cells
- Plasma antibodies
- ITGAM
- Mice
The paper
Instituto Murciano de Investigación Biosanitaria
Cells, Oct 28, 2026, Open access, CC BY
